Optimizing aztreonam/ceftazidime-avibactam for difficult-to-treat Stenotrophomonas maltophilia pneumonia: the importance of continuous infusion and therapeutic drug monitoring - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Optimizing aztreonam/ceftazidime-avibactam therapy for difficult-to-treat Stenotrophomonas maltophilia pneumonia: roles of continuous infusion and therapeutic drug monitoring

  • By

  • Patrick M. Honoré

  • Yasser Benkaddour

  • Hamza Slibani

  • Catherine Yildiz Muscato

  • November 11, 2026

Share

Original Source(s)

Related Content